Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: How to lower the rate of bacterial vaginosis recurrences

New Microbiologica

Volumn 31, Issue 3, 2008, Pages 429-433

  Marcone, Valentina ^a   Calzolari, Ettore ^a   Bertini, Marco ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Lactobacilli; Probiotics; Vaginosis

Indexed keywords

ANTIINFECTIVE AGENT; METRONIDAZOLE; PROBIOTIC AGENT;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; LACTOBACILLUS RHAMNOSUS; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; LACTOBACILLUS RHAMNOSUS; METRONIDAZOLE; PROBIOTICS; RECURRENCE; VAGINOSIS, BACTERIAL;

BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS RHAMNOSUS;

EID: 52749090274     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. ALLSWORT J.E., PEIPERT J.F. (2007). Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet. Gynecol. 109, 114-120.
2. AMSEL R., TOTTEN P.A., SPIEGEL C.A., CHEN K.C., ESCHENBACH D., HOLMES K.K. (1983). Non-specific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74, 14-22.
3. ANUKAM K., BRUCE A., REID G. (2006). Clinical study comparing probiotic Lactobacillus GR-I an RC-14 with metronidazole vaginal gel to treat symptomatic bacterial vaginosis. Microbes and Infection. 8, 2772-2776.
4. BLACKWELL A.L., FOX A.R., PHILLIPS I., BARLOW D. (1983). Anaerobic vaginosis (non-specific vaginitis): clinical, microbiological, and therapeutic findings. Lancet. 2, 1379-1382.
5. BRUCE A.W., REID G., MC GROARTY J.A. (1992). Preliminary study on the prevention of recurrent urinary tract infection in adult women using intravaginal Lactobacilli. Int. Urogynecol. J. 3, 22-25.
6. BUTLER B.C., BEAKLEY J.W. (1960). Bacterial flora in vaginitis: a study before and after treatment with pure cultures of Doderlein bacillus. Am. J. Obstet. Gynecol. 79, 432-440.
7. CADIEUX P., REID G.P., BURTON J., GARDINER G., BRAUNSTEIN I., BRUCE A.W., KANG C.Y., REID G. (2002). Lactobacillus strains and vaginal ecology. JAMA. 278, 1940-1941.
8. CALZOLARI E., MASCIANGELO R., MILITE V, VERTERAMO R. (2000). Bacterial Vaginosis and contraceptive methods. Int. J. Gynecol. Obstet. 70, 341-346.
9. CAUCI S., DRIUSSI S., MONTE R., LANZAFAME P., PITZUS E., QUADRIFOGLIO F. (1997). Immunoglobulin A response against Gardnerella vaginalis hemolysin and sialidase activity in bacterial vaginosis. Am. J. Obstet. Gynecol. 177, 1184-1187.
10. CDC-CENTERS FOR DISEASE CONTROL AND PREVENTION. (2006). STD treatment guidelines. Donders G., Gilbert G.G., Bosnians E., Dekeersmaecker A., Vereecken A., Pharm B., Van Bulck B., Spitz B. (2000). Pathogenesis of abnormal vaginal flora. Am. J. Obstet. Gynecol. 182, 872-878.
11. EVANS A.L., SCALLY A.J., WELLARD S.J., WILSON J.D. (2007). Prevalence of bacterial vaginosis in lesbians and heterosexual women in a community setting. Sex. Transm. Infect. Published Online First: 4 July 2007.
12. FAMULARO G., PIELUIGI M., COCCIA R., MASTROIACOVO P., DE SIMONE C. (2001). Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Medical Hypotheses. 56, 421-430.
13. FAO/WHO. (2002). Guidelines for the evaluation of probiotics in food. Report of a joint FAO/WHO working group 2002. www.fao.org./ag/agn/food/ food_probiocons_en.stm.
14. GARDINER G.E., HEINEMANN C., BRUCE A.W., BEUERMAN D., REID G. (2002). Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1 but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin. Diagn. Lab. Imninnol. 9, 92-96.
15. HAY P. (2005). Bacterial vaginosis. Medicine. 33, 58-61.
16. HOLMES K.K., SPIEGKEL C., AMSEL R., ESCHENBACH D.A., CHEN K.C.S., TOTTEN P. (1981). Nonspecific vaginosis. Scan. J. Infect. Dis. 26, 110-114.
17. LAMONT R.F., MORGAN D.J., WILDEN S.D., TAYLOR-ROBINSON D. (2000). Prevalence of bacterial vaginosis in women attending one of three general practices for routine cervical cytology. Int. J. STD & AIDS. 11, 495-498.
18. LARSSON P.G., PLATZ-CHRISTENSEN J.J., SUNDSTROM E. (1991). Is bacterial vaginosis a sexually transmitted disease? Int. J. STD & AIDS. 2, 362-364.
19. th World congress for infectious and immunological dieseases in obstetrics and gynecology. Venice. 166-167.
20. MC LEAN N., ROSENSTEIN I.J. (2000). Characterisation and selection of a Lactobacillus species to recolonise the vagina of women with recurrent bacterial vaginosis. J. Med. Microbiol. 49, 543-552.
21. MOLHER R.W., BROWN C.P. (1933). Doderlein's bacillus in the treatment of vaginitis. Am. J. Obstet. Gynecol. 25, 718-723.
22. MORRIS M., NICOLL A., SIMMS I., WILSON J., CATCHPOLE M. (2001). Bacterial vaginosis: a public health review. Br. J. Obstet. Gynecol. 108, 439-450.
23. RAUTH V.A., CULHANE J.F., HOGAN V.K. (2000). Bacterial Vaginosis: a public health problem for women. J. Am. Worn. Assoc. 55, 220-224.
24. REID G., BURTON J. (2002). Use of lactobacillus to prevent infection by pathogenic bacteria. Microbes and Infection. 4, 319-324.
25. REID G.K., MILLS A.P., BRUCE A.W. (1994). Implantation of Lactobacilli Casei var-rhamnosus into the vagina. The Lancet. 344, 1229.
26. REID G., BRUCE A.W., MC GROARTY J.A., CHENG KJ., COSTERTON J.W. (1990). Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin. Microbiol. Rev. 3, 335-344.
27. ROMERO R., ESPINOZA J., CHAIWORAPONGSA T., KALACHE K. (2002). Infections and prematurity: the role of preventive strategies. Semin. Neonat. 7, 259-274.
28. ROSSI A., CATTADORI F., SCIENZA G., CORTI BOLLA E., CHIANTERA V., BERTINI M. (1999). Therapy of recurrent perimenarchcal vaginitis using exogenously-applied Lactobacilli Casei sub-rhamnosus. J. Clin. Rex. 2, 173-178.
29. SHA B.E., ZARIFFARD M.R., WANG Q.J., CHEN H.Y., BREMER J., COHEN M.H., SPEA G.T. (2005). Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with Bacterial Vaginosis and Mycoplasma hominis. The Journal of Infectious Diseases. 191, 25-32.
30. SCHMID G.P. (1999). The epidemiology of bacterial vaginosis. Int. J. Obstet. Gynecol. 67, S17-S20.
31. SPIEGEL C.A. (1991). Bacterial Vaginosis. Clin. Microb. Rev. 4, 485.
32. TAHA T.E., HOOVER D.R., DALLABETTA G.A., KUMWENDA N.I., MTIMAVALYE L.A.R., YANG L.P., LIOMBA G.N., BROADHEAD R.L., CHIPHANGWI J.D., MIOTTI P.G. (1998). Bacterial vaginosis and disturbance of vaginal flora: associated with incresed acquisition of HIV. AIDS. 12, 1699-1706.
33. TOLOSA J.S., CHAITHONGWONGWATTHANA S.D., MAW W., GAITÀN H., LUMBIGANON P., FESTIN M., CHIPATO T., SAUVARIN J., GOLDENBERG R. (2006). The international infection in pregnancy (IIP) study: variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women; Am. J. Obst. Gynecol 195, 1198-1204.
34. WANG J. (2000) Bacterial vaginosis. Primary care update for OB/GYNS 7, 181-185.